Florey biotech spin-out secures seed investment from Curie.Bio
By API User
Melbourne-based Alkira Bio, a novel drug discovery platform company, announces seed investment from Curie.Bio. Alkira Bio uses its proprietary LASEREDD® technology platform to discover therapeutic antibodies directed against previously out of reach targets, pioneering new possibilities for drug discovery. The seed financing from Curie.Bio recognises Alkira Bio’s advanced understanding in targeting complex membrane proteins called … Continued